-
SW033291: Designing Better Regeneration Assays
2026-08-13
SW033291 is a potent 15-PGDH inhibitor for studying prostaglandin E2 elevation, hematopoiesis stimulation, and tissue repair. This guide focuses on assay design, target-engagement controls, and how recent muscle-regeneration findings should shape experimental interpretation.
-
IEM 1460: AMPA Receptor Blocker Workflows
2026-08-12
IEM 1460 enables controlled AMPA receptor inhibition assays for dissecting excitotoxicity, synaptic signaling, and neuroprotection. This workflow-focused guide connects receptor-selective experiments with lessons from a recent in vivo glutamate-receptor study while clearly separating validated findings from practical optimization recommendations.
-
KG-501 for CREB–CBP Transcription Studies
2026-08-12
KG-501 provides a practical way to test CREB–CBP coactivator recruitment in cancer and macrophage assays, complementing receptor-level pathway experiments. This workflow connects transcriptional coactivator disruption with proliferation, differentiation, inflammatory polarization, and colorectal cancer research while preserving essential controls for compound solubility and pathway specificity.
-
MitMAB: Causal Mapping of Organoid Uptake
2026-08-11
MitMAB enables causal analysis of dynamin-dependent uptake in intestinal organoid systems. This article connects the compound’s mechanism with organoid orientation, extracellular vesicle biology, and more defensible intracellular trafficking research decisions.
-
MALAT1 Levels Shape TDP-43 RNA Binding and Cell Viability
2026-08-11
The reference study shows that MALAT1 abundance influences both cell survival and the distribution of TDP-43 binding across mRNA transcripts. Its results support a dosage-sensitive RNA–protein network in which MALAT1 can modify TDP-43 function, including during MPP+-induced neuronal stress.
-
NSC 87877: Shp2 Inhibitor Workflow
2026-08-10
NSC 87877 is a Shp2-focused small molecule for dissecting phosphatase activity, EGF–Ras–Erk signaling, leukemia-cell responses, and SHP2-linked neuroinflammation. This workflow emphasizes assay controls, concentration planning, and the distinction between direct pharmacological inhibition and tFUS-mediated regulation after ischemic stroke.
-
Spiroplasma Entry into S2 Cells and Endocytic Routes
2026-08-09
Wei et al. established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris invades insect cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological pathway inhibition, cytoskeletal perturbation, and infection-associated stress measurements together provide a useful framework for studying this poorly characterized host–pathogen interaction.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow
2026-08-08
Build a quantitative mRNA delivery and translation efficiency assay around one payload with two independent readouts: Cy5 tracks intracellular trafficking, while EGFP reports functional translation. This workflow also shows how polymer-micelle binding data can guide nanoparticle screening, macrophage studies, and delivery-system troubleshooting.
-
Ang II–HIF-1α–HILPDA Axis in NPC Radioresistance
2026-08-07
The reference study identifies local angiotensin II as a regulator of ferroptosis and radiotherapy resistance in nasopharyngeal carcinoma through an AGT–HIF-1α–HILPDA feedback circuit. Its combination of resistant cell models, mechanistic assays, tissue analysis, and xenograft experiments supports dual Ang II blockade and ferroptosis induction as a radiosensitization strategy, while also defining important limits for translation.
-
FAISL lncRNA Blocks FAK Proteolysis to Drive TNBC Progressio
2026-08-07
The reference study reveals that the long noncoding RNA FAISL promotes progression and metastasis of triple negative breast cancer (TNBC) by inhibiting Calpain 2-mediated proteolysis of focal adhesion kinase (FAK). This mechanism highlights FAISL as a critical regulator of FAK stability and a potential therapeutic target in aggressive breast cancers.
-
LncRNA FAISL Blocks Calpain-2 Cleavage of FAK in TNBC Progre
2026-08-06
This study identifies the long non-coding RNA FAISL as a key stabilizer of FAK protein in triple negative breast cancer (TNBC) by selectively inhibiting calpain-2-mediated proteolysis. These findings reveal a novel post-translational regulatory axis in TNBC metastasis and suggest new avenues for targeted intervention and protease inhibition assays.
-
Fluoxetine HCl: Protocols for Motivation and Neurogenesis Re
2026-08-06
Fluoxetine HCl is a selective serotonin reuptake inhibitor uniquely suited to dissecting serotonergic signaling and motivational circuits in preclinical models. With robust solubility in DMSO and ethanol, it empowers research into neurogenesis, depression, and reward processing—especially when interpreting long-term behavioral outcomes of early-life SSRI exposure.
-
Histone H4K12 Lactylation Drives TNBC Progression via SLFN5
2026-08-05
This study uncovers a lactate-driven epigenetic mechanism in triple-negative breast cancer (TNBC): histone H4K12 lactylation suppresses SLFN5, facilitating tumor progression. By showing that LDH-A inhibition with sodium oxamate reverses these effects, the research highlights a direct metabolic-epigenetic axis and suggests new avenues for targeting metabolic reprogramming in aggressive cancers.
-
Dynasore in Cellular Infection Models: Beyond Endocytosis In
2026-08-05
Explore the multifaceted applications of Dynasore as a dynamin GTPase inhibitor, uniquely focusing on its role in dissecting pathogen-host interactions and clathrin-mediated endocytosis. This article delivers new scientific insights for advanced endocytosis research.
-
Spiroplasma eriocheiris Entry: Clathrin-Mediated Endocytosis
2026-08-04
This study elucidates how Spiroplasma eriocheiris invades Drosophila S2 cells, revealing a reliance on clathrin-mediated endocytosis and macropinocytosis. By employing dynamin GTPase inhibitors such as Dynasore, the research establishes mechanistic insights critical to endocytosis research and pathogen-host interactions.